Literature DB >> 21454876

Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation.

Elizabeth Byrne, Chrissy Giles, Joanne Andrews, Amin Rahemtulla, Kikkeri N Naresh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21454876      PMCID： PMC3069252          DOI： 10.3324/haematol.2011.041509

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

1.  Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.

Authors:  S Hovenga; J T de Wolf; J E Guikema; H Klip; J W Smit; C T Smit Sibinga; N A Bos; E Vellenga
Journal:  Bone Marrow Transplant       Date:  2000-04       Impact factor: 5.483

2.  Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents.

Authors:  Carlos Fernández de Larrea; Natalia Tovar; M Teresa Cibeira; Juan I Aróstegui; Laura Rosiñol; Montserrat Elena; Xavier Filella; Jordi Yagüe; Joan Bladé
Journal:  Haematologica       Date:  2010-09-30       Impact factor: 9.941

3.  Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation.

Authors:  C S Zent; C S Wilson; G Tricot; S Jagannath; D Siegel; K R Desikan; N Munshi; D Bracy; B Barlogie; A W Butch
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

4.  Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation.

Authors:  Sara L Hall; Jill Tate; Devinder Gill; Peter Mollee
Journal:  Clin Biochem Rev       Date:  2009-08
  4 in total
  3 in total

1.  Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.

Authors:  Marian F Schmitz; Henny G Otten; Laurens E Franssen; Suzanne van Dorp; Theo Strooisma; Henk M Lokhorst; Niels W C J van de Donk
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

2.  Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.

Authors:  Natalia Tovar; Carlos Fernández de Larrea; Juan I Aróstegui; Maria Teresa Cibeira; Laura Rosiñol; Montserrat Rovira; Montserrat Elena; Xavier Filella; Jordi Yagüe; Joan Bladé
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

3.  oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.

Authors:  Manabu Fujisawa; Keisuke Seike; Kouta Fukumoto; Yasuhito Suehara; Masafumi Fukaya; Hiroki Sugihara; Masami Takeuchi; Kosei Matsue
Journal:  Cancer Sci       Date:  2014-10-09       Impact factor: 6.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.